Humana Inc. (HUM) is a major health-insurance and managed-care company that offers a broad range of medical and specialty insurance products across the United States. Headquartered in Louisville, Kentucky, Humana operates through two primary business segments: Insurance and CenterWell, providing services such as Medicare and Medicaid plans, supplemental benefit plans, pharmacy benefit management, senior-centered primary-care services, home health, hospice, and more. The market cap of Humana is around $30.9 ...

Core Thesis - Centene Corporation (CNC) is viewed as a deep value opportunity with a current share price of $39.34 and a cost basis for investors at $28.15 per share, indicating a discounted valuation relative to its fundamental strength [1][2]. Company Overview - Centene Corporation operates as a healthcare enterprise providing services to under-insured and uninsured families, as well as commercial organizations in the United States [2]. - As the largest Medicaid provider in the U.S., CNC is positioned as a dominant low-cost player in a specialized segment of the healthcare industry, benefiting from scale advantages [3]. Financial Metrics - The estimated maximum liquidation value of Centene exceeds its current market capitalization by over 50%, suggesting substantial potential gains through asset sales [4]. - CNC's seven-year average owner earnings are approximately $2.37 billion, indicating that investors could recoup their investment in about eight years at the current valuation, or in closer to four years if recent earnings levels are maintained [4]. Investment Strategy - The investment strategy involves holding CNC shares unless a superior opportunity arises or there is a significant change in the company's or industry's fundamentals [5]. - A key aspect of the investment thesis is the ability of healthcare insurers to raise prices over time, which supports earnings durability and incremental value creation [5]. Market Context - The broader profitability upswing expected across health insurers is driven by the short-tail nature of healthcare risk, allowing for pricing resets and margin recovery [3].

HARTFORD, Conn., Dec. 4, 2025 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), today announces key milestones in support of the company's comprehensive strategy announced in June to remove friction in the healthcare system and improve the experience for healthcare professionals and their patients. Continue Reading "Aetna committed to several bold actions earlier this year that were intended to improve the American healthcare industry and I'm proud of the progress we've made against these commitments ...

With a market cap of $19.1 billion, Centene Corporation (CNC) is a U.S.-based healthcare enterprise that serves under-insured and uninsured individuals, as well as commercial organizations. It operates through four key segments: Medicaid; Medicare; Commercial; and Other, offering a wide range of health programs and related services. Companies valued over $10 billion are generally described as “large-cap” stocks, and Centene fits right into that category. The company delivers care through networks of physi ...

One pundit following the company envisions notable improvements in both UnitedHealth and Optum.An analyst's price target increase for UnitedHealth Group (UNH +4.67%) stock was taken to heart by investors on Wednesday. Following news of the boost, they collectively pushed the large health insurer's stock up by almost 5% that trading session. 14% more optimisticThe person behind the raise was Wolfe Research prognosticator Justin Lake. Well before market open that day, he upped his price target on UnitedHealth ...

The health insurance giant's stock got a big boost after Wall Street learned Berkshire Hathaway had invested in it.For years, UnitedHealth Group (UNH +4.82%) has been one of the best growth stocks to own on the New York Stock Exchange. A leading health insurance company, it generated solid and continuous growth, and many investors viewed it as a safe stock to own and also a reliable dividend investment.However, it's been facing some considerable challenges of late, including rising costs and a Department of ...

Core Insights - The Cigna Group's 2025 Vitality in America report reveals that fewer than one in three American adults have a strong sense of purpose, which is linked to higher vitality, better health, and stronger relationships [1][2] Group 1: Sense of Purpose and Vitality - Individuals with a strong sense of purpose report vitality scores of 88.9, compared to 61.3 for those without purpose [1] - People lacking purpose are 2-3 times more likely to feel depressed and five times less likely to feel energized [1] - Among those with mental health conditions, individuals without a clear sense of purpose are twice as likely to struggle with initiative and nearly three times as likely to feel low enthusiasm [1] Group 2: Health Behaviors - Individuals without purpose are less likely to have annual physical or dental exams and are half as likely to wake feeling rested [1] - Only 36% of those lacking purpose practice mindful nutrition, while 84% of those with strong purpose feel in control over their future health [1] Group 3: Relationships and Community Engagement - People with a strong sense of purpose are more likely to engage in community activities, with 42% volunteering compared to 26% of those without purpose [1] - Those lacking purpose are half as likely to prioritize relationships, with only 41% making time for desired connections [1] Group 4: Workplace Engagement - Employees without a clear sense of purpose are more likely to be disengaged, burned out, and seeking new jobs, leading to absenteeism and turnover [1][2] - Purpose-driven employees exhibit greater resilience, motivation, and commitment, resulting in stronger business outcomes [2]

Legal (Peter R.) LGTM 12/2 Disclaimer Investor Presentation December 2025 LGTMs: Date: Peter K. LGTM 12/1 This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") expectations regarding Adjusted EBITDA, Adjusted Net income from continuing operations, Adjusted SG&A, Adjusted SG&A as a percentage of revenue, Insurance BER, Normaliz ...

Core Points - The article discusses the expansion of short-term health insurance plans under the Trump administration as a response to rising healthcare costs and the expiration of enhanced ACA subsidies in 2026 [6][10] - Short-term plans are cheaper than ACA coverage but lack essential health benefits and protections for preexisting conditions, leading to concerns about their adequacy [11][12] Group 1: Short-Term Insurance Plans - Short-term health insurance plans, also known as "short-term limited duration insurance," are designed to provide temporary coverage for individuals between other insurance options [4] - The Trump administration's 2018 executive order allowed these plans to last up to three years, significantly extending their duration compared to the previous limit of four months [1][10] - These plans are typically about half the cost of ACA plans, with a 40-year-old nonsmoker in Florida paying approximately $320 for short-term coverage compared to $500 for ACA coverage [11] Group 2: Regulatory Changes and Consumer Impact - The Biden administration tightened regulations on short-term plans in 2024, limiting their duration to four months and requiring clearer disclosures about coverage limitations [10] - Critics argue that short-term plans can mislead consumers into thinking they have comprehensive coverage, which they do not, leading to potential financial risks [5][13] - Some states, including New York and California, have banned the sale of short-term plans due to their inadequate coverage [12] Group 3: Market Reactions and Consumer Choices - The article highlights a divide in opinions regarding short-term plans, with some officials advocating for their expansion as a cost-saving measure for those excluded from the ACA [7] - Consumers are encouraged to assess their health needs and consider high-deductible plans paired with health savings accounts as alternatives to short-term insurance [14][15] - The article emphasizes the importance of understanding the limitations of short-term plans and suggests that they should only be viewed as temporary solutions [17]

Core Viewpoint - Rosen Law Firm is urging investors of Molina Healthcare, Inc. to secure legal counsel before the December 2, 2025 deadline for a securities class action lawsuit related to undisclosed adverse facts affecting the company's financial guidance and operations [1][5]. Group 1: Class Action Details - The class action pertains to Molina securities purchased between February 5, 2025, and July 23, 2025, with a lead plaintiff deadline set for December 2, 2025 [1][2]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. Group 2: Allegations Against Molina - The lawsuit claims that Molina failed to disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [5]. - It is alleged that Molina's growth was reliant on limited utilization of various health services, which could lead to a significant cut in financial guidance for fiscal year 2025 [5]. - The lawsuit asserts that positive statements made by Molina regarding its business and prospects were materially misleading due to the undisclosed adverse facts [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and being ranked highly for securities class action settlements [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, highlighting the firm's expertise in this area [4].